{
    "organizations": [],
    "uuid": "cc003c9a3e40d343250f310c76018dfa0e54b962",
    "author": "",
    "url": "https://www.reuters.com/article/brief-itus-and-serametrix-announce-resul/brief-itus-and-serametrix-announce-results-of-a-blinded-prostate-cancer-study-idUSFWN1R90A7",
    "ord_in_thread": 0,
    "title": "BRIEF-Itus And Serametrix Announce Results Of A Blinded Prostate Cancer Study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 23 AM / Updated 7 minutes ago BRIEF-Itus And Serametrix Announce Results Of A Blinded Prostate Cancer Study Reuters Staff March 27 (Reuters) - Itus Corp: * ITUS AND SERAMETRIX ANNOUNCE RESULTS OF A BLINDED PROSTATE CANCER STUDY * ITUS- ALONG WITH SERAMETRIX, CO EVALUATING WHETHER CCHEK MAY BE UTILIZED TO DISTINGUISH BETWEEN RESPONDERS AND NON-RESPONDERS TO IMMUNE-THERAPIES * ITUS CORP - ITUS CORRECTLY IDENTIFIED 33 OF 36 PROSTATE CANCER SAMPLES AND 34 OF 37 HEALTHY DONOR SAMPLES Source text for Eikon: Further company coverage:",
    "published": "2018-03-27T14:19:00.000+03:00",
    "crawled": "2018-03-27T14:33:18.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "serametrix",
        "announce",
        "result",
        "blinded",
        "prostate",
        "cancer",
        "study",
        "reuters",
        "staff",
        "march",
        "reuters",
        "itus",
        "corp",
        "itus",
        "serametrix",
        "announce",
        "result",
        "blinded",
        "prostate",
        "cancer",
        "study",
        "along",
        "serametrix",
        "co",
        "evaluating",
        "whether",
        "cchek",
        "may",
        "utilized",
        "distinguish",
        "responder",
        "itus",
        "corp",
        "itus",
        "correctly",
        "identified",
        "prostate",
        "cancer",
        "sample",
        "healthy",
        "donor",
        "sample",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}